Steven Lane
Impact in
- Hematology top 0.5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
- Genetics top 0.5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 68
- Acute Myeloid Leukemia Research 47
- Chronic Myeloid Leukemia Treatments 17
- Hematopoietic Stem Cell Transplantation 16
- Genetics 33
- Myeloproliferative Neoplasms: Diagnosis and Treatment 18
- Chronic Lymphocytic Leukemia Research 9
- Co-authors
- David A. WilliamsD. Gary GillilandFiona M. WattDavid T. ScaddenMunir PirmohamedDyfrig HughesLars BullingerScott A. Armstrong
- Journals
- Blood (32 papers)PLoS ONE (13 papers)The Journal of Physician Assistant Education (9 papers)Blood Advances (4 papers)Leukemia (4 papers)
- Partner nations
- United KingdomAustraliaUnited States
In The Last Decade
Steven Lane
204 papers receiving 5.9k citations
Hit Papers
Peers
Comparison fields: 5 of 153
- Hematology 1.8k
- Genetics 1.2k
- Immunology 984
- Molecular Biology 2.1k
- Oncology 801
Countries citing papers authored by Steven Lane
This map shows the geographic impact of Steven Lane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Lane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Lane more than expected).
Fields of papers citing papers by Steven Lane
This network shows the impact of papers produced by Steven Lane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Lane. The network helps show where Steven Lane may publish in the future.
Co-authors
The 25 scholars most cited alongside Steven Lane, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 10 | |
| 8 | 2023 | 7 | |
| 9 | 2022 | 25 | |
| 10 | 2021 | 4 | |
| 11 | Just As Good but Better Tolerated: Posaconazole As First-line Therapy for Invasive Aspergillosis | 2021 | 0 |
| 12 | 2021 | 7 | |
| 13 | Not All TP53 Mutations Are Equal | 2021 | 1 |
| 14 | 2020 | 29 | |
| 15 | 2018 | 14 | |
| 16 | 2018 | 22 | |
| 17 | 2015 | 13 | |
| 18 | Ssb2/Nabp1 is dispensable for thymic maturation, male fertility, and DNA repair in mice | 2015 | 2 |
| 19 | 2013 | 126 | |
| 20 | 2012 | 15 |
About Steven Lane
Steven Lane is a scholar working on Hematology, Genetics, Family Practice, Immunology and Psychiatry and Mental health, having authored 229 papers that have together received 6.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (47 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (18 papers), Chronic Myeloid Leukemia Treatments (17 papers), Hematopoietic Stem Cell Transplantation (16 papers), Sepsis Diagnosis and Treatment (12 papers), Chronic Lymphocytic Leukemia Research (9 papers), Immune Cell Function and Interaction (9 papers) and Pregnancy-related medical research (8 papers). The work is most often cited by research in Hematology (1.8k citations), Genetics (1.2k citations), Immunology (984 citations), Molecular Biology (2.1k citations) and Oncology (801 citations). Steven Lane has collaborated with scholars based in United Kingdom, Australia and United States. Frequent co-authors include David A. Williams, D. Gary Gilliland, Fiona M. Watt, David T. Scadden, Munir Pirmohamed, Dyfrig Hughes, Lars Bullinger, Scott A. Armstrong, Benjamin L. Ebert and D. Gary Gilliland. Their work appears in journals such as Blood, PLoS ONE, The Journal of Physician Assistant Education, Blood Advances and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.